Does EVOLOCUMAB Cause Atrial fibrillation? 333 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 333 reports of Atrial fibrillation have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
333
Reports of Atrial fibrillation with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
5
Deaths
108
Hospitalizations
How Dangerous Is Atrial fibrillation From EVOLOCUMAB?
Of the 333 reports, 5 (1.5%) resulted in death, 108 (32.4%) required hospitalization, and 4 (1.2%) were considered life-threatening.
Is Atrial fibrillation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 333 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Atrial fibrillation?
APIXABAN (5,690)
IBRUTINIB (3,671)
LENALIDOMIDE (2,704)
RITUXIMAB (2,100)
SACUBITRIL\VALSARTAN (2,062)
RIVAROXABAN (2,027)
ADALIMUMAB (1,709)
METOPROLOL (1,462)
DEXAMETHASONE (1,461)
METHOTREXATE (1,411)
Which EVOLOCUMAB Alternatives Have Lower Atrial fibrillation Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE